Late Presentation of β-Thalassemia Major Patient With Left Hemiparesis: A Case Report

被引:0
作者
Hussain, Ashwaq [1 ]
Singh, Ajay [2 ]
Arora, Sanjiya [3 ]
Gupta, Varnika [4 ]
Mallimala, Priya R. [5 ]
机构
[1] Thalassemia & Sickle Cell Soc, Hematol, Kurnool, India
[2] Sri Ram Murti Smarak Inst Med Sci, Internal Med, Bareilly, India
[3] Rohilkhand Med Coll & Hosp, Internal Med, Bareilly, India
[4] Lala Lajpat Rai Mem Med Coll, Internal Med, Meerut, India
[5] Kurnool Med Coll, Internal Med, Kurnool, India
关键词
iron overload; blood transfusion; cerebral atrophy; hemiparesis; beta-thalassemia;
D O I
10.7759/cureus.52280
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Thalassemia is a hereditary autosomal recessive disorder that is distinguished by a diminished rate of hemoglobin (Hb) synthesis arising from an anomaly in the synthesis of a or 13 globin chains. Classical symptoms of 13-thalassemia are frequently observed in patients who present late for blood transfusion (BT), which is typical among South Asian countries in light of their limited resources. This case report is an uncommon instance of a typical occurrence that has been infrequently reported in the South Asian region. The reporting of this case will assist healthcare workers in managing cases appropriately. We present a 12year-old female child diagnosed with 13-thalassemia major with a late presentation than usual accompanied by an unusual finding of left hemiparesis at a young age of five years. The patient had been lost to follow-up, presented with easy fatiguability, poor weight gain, and growth restriction, all of which are classic symptoms of 13-thalassemia. The patient was treated with a BT and continued to be monitored for transfusion and iron overload management.
引用
收藏
页数:6
相关论文
共 12 条
[1]   Visual failure caused by suprasellar extramedullary hematopoiesis in beta thalassemia: Case report [J].
Aarabi, B ;
Haghshenas, M ;
Rakeii, V .
NEUROSURGERY, 1998, 42 (04) :922-925
[2]   Thalassemias: An Overview [J].
Angastiniotis, Michael ;
Lobitz, Stephan .
INTERNATIONAL JOURNAL OF NEONATAL SCREENING, 2019, 5 (01)
[3]  
Ansari B, 2017, CASE REP NEUROL MED, V2017, DOI 10.1155/2017/2736402
[4]  
Banjade P, 2020, J NEPAL MED ASSOC, V58, P436, DOI [10.31729/jnma.5129, 10.31729/jnma.5129CCBY]
[5]  
Cao A, 2010, GENET MED, V12, P61, DOI [10.1038/gim.2016.173, 10.1097/GIM.0b013e3181cd68ed]
[6]  
Chen Shuqi, 1996, American Journal of Physiology, V270, pH1951
[7]   β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical Standpoint [J].
De Sanctis, Vincenzo ;
Kattamis, Christos ;
Canatan, Duran ;
Soliman, Ashraf T. ;
Elsedfy, Heba ;
Karimi, Mehran ;
Daar, Shahina ;
Wali, Yasser ;
Yassin, Mohamed ;
Soliman, Nada ;
Sobti, Praveen ;
Al Jaouni, Soad ;
El Kholy, Mohamed ;
Fiscina, Bernadette ;
Angastiniotis, Michael .
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2017, 9
[8]   Gene Therapy For Beta-Thalassemia: Updated Perspectives [J].
Karponi, Garyfalia ;
Zogas, Nikolaos .
APPLICATION OF CLINICAL GENETICS, 2019, 12 :167-180
[9]   Cerebral infarction in β-thalassemia intermedia: Breaking the silence [J].
Musallam, Khaled M. ;
Taher, Ali T. ;
Karimi, Mehran ;
Rachmilewitz, Eliezer A. .
THROMBOSIS RESEARCH, 2012, 130 (05) :695-702
[10]   Pathophysiology and Clinical Manifestations of the β-Thalassemias [J].
Nienhuis, Arthur W. ;
Nathan, David G. .
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2012, 2 (12)